| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |